trade war

Biotech execs criticize ‘atmosphere of intimidation’ amid actions against Chinese scientists

More than 150 people - including biotechnology and investment executives and academics - have signed a letter warning that actions dismissals of Chinese scientists create a hostile climate that threatens U.S. leadership in biomedical science.

By Alaric DeArment

BioPharma, Policy

US-China trade war gets mixed reviews from Chinese attendees at BIO

Some Chinese attendees said they are not yet affected but maybe while others said they weren't affected and that the trade impasse was likely to turn the attention of the biotech companies to Europe. Chinese pharma wouldn't be affected.

By Alaric DeArment